| Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus AA Khan, A Morrison, DA Hanley, D Felsenberg, LK McCauley, F O'Ryan, ... Journal of Bone and Mineral Research 30 (1), 3-23, 2015 | 1451 | 2015 |
| Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy MF Holick, ES Siris, N Binkley, MK Beard, A Khan, JT Katzer, ... The Journal of Clinical Endocrinology & Metabolism 90 (6), 3215-3224, 2005 | 1279 | 2005 |
| Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Journal of British Surgery 107 (11), 1440-1449, 2020 | 1133 | 2020 |
| Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop JP Bilezikian, AA Khan, JT Potts Jr, ... The Journal of Clinical Endocrinology & Metabolism 94 (2), 335-339, 2009 | 1012 | 2009 |
| Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research JP Bilezikian, A Khan, JT Potts Jr, ML Brandi, BL Clarke, D Shoback, ... Journal of Bone and Mineral Research 26 (10), 2317-2337, 2011 | 639 | 2011 |
| Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus AA Khan, DA Hanley, R Rizzoli, J Bollerslev, JEM Young, L Rejnmark, ... Osteoporosis International 28, 1-19, 2017 | 567 | 2017 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 531* | 2021 |
| Hyperparathyroidism JP Bilezikian, L Bandeira, A Khan, NE Cusano The Lancet 391 (10116), 168-178, 2018 | 515 | 2018 |
| Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic … A Chanan-Khan, P Cramer, F Demirkan, G Fraser, RS Silva, S Grosicki, ... The Lancet Oncology 17 (2), 200-211, 2016 | 505 | 2016 |
| Management of hypoparathyroidism: summary statement and guidelines ML Brandi, JP Bilezikian, D Shoback, R Bouillon, BL Clarke, RV Thakker, ... The Journal of Clinical Endocrinology & Metabolism 101 (6), 2273-2283, 2016 | 409 | 2016 |
| Presentation of hypoparathyroidism: etiologies and clinical features DM Shoback, JP Bilezikian, AG Costa, D Dempster, H Dralle, AA Khan, ... The Journal of Clinical Endocrinology & Metabolism 101 (6), 2300-2312, 2016 | 352 | 2016 |
| Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial AA Khan, JP Bilezikian, AWC Kung, MM Ahmed, SJ Dubois, AYY Ho, ... The Journal of Clinical Endocrinology & Metabolism 89 (7), 3319-3325, 2004 | 347 | 2004 |
| Primary hyperparathyroidism JP Bilezikian, NE Cusano, AA Khan, JM Liu, C Marcocci, F Bandeira Nature reviews Disease primers 2 (1), 1-16, 2016 | 326 | 2016 |
| Medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline N Yarom, CL Shapiro, DE Peterson, CH Van Poznak, K Bohlke, ... Journal of Clinical Oncology 37 (25), 2270-2290, 2019 | 320 | 2019 |
| COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation D Kempuraj, GP Selvakumar, ME Ahmed, SP Raikwar, R Thangavel, ... The Neuroscientist 26 (5-6), 402-414, 2020 | 305 | 2020 |
| Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw AA Khan, GKB Sandor, E Dore, AD Morrison, M Alsahli, F Amin, E Peters, ... The Journal of rheumatology 35 (7), 1391-1397, 2008 | 276 | 2008 |
| Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 271 | 2019 |
| Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ AA Khan, A Morrison, DL Kendler, R Rizzoli, DA Hanley, D Felsenberg, ... Journal of clinical densitometry 20 (1), 8-24, 2017 | 255 | 2017 |
| Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays JP Brown, S Morin, W Leslie, A Papaioannou, AM Cheung, KS Davison, ... Canadian Family Physician 60 (4), 324-333, 2014 | 246 | 2014 |
| Bisphosphonate associated osteonecrosis of the jaw AA Khan, GKB Sandor, E Dore, AD Morrison, M Alsahli, F Amin, E Peters, ... The Journal of rheumatology 36 (3), 478-490, 2009 | 243 | 2009 |
